AI-generated content for informational purposes only. Not financial advice. Always do your own research.

소개

UnitedHealth Group(NYSE: UNH)은 매출 기준 세계 최대 헬스케어 기업이자 시가총액 기준 가장 가치 있는 헬스 종목으로, 두 개의 주요 부문을 통해 운영됩니다: 5천만 명이 넘는 회원을 보장하는 미국 최대 건강보험 제공업체 UnitedHealthcare와, 약국 급여 관리, 진료 제공, 데이터 분석을 아우르는 다각화된 헬스 서비스 사업 Optum입니다. Optum 부문은 의사 진료소, 외래 수술 센터, 가정 건강 서비스를 통한 직접 의료 제공으로 확장하며 수직 통합 헬스케어 기업을 형성하는 핵심 성장 엔진이었습니다. UnitedHealth Group은 입증된 경영진, 일관된 두 자릿수 이익 성장, 10년 이상 배당 인상 실적을 갖춘, 헬스 서비스 전 영역에 대한 노출을 제공하는 지배적인 헬스케어 투자처입니다.

고령화 인구 주식

UnitedHealth Group은 세계 최대의 의료 회사로, 국내 최대 건강보험사(UnitedHealthcare)와 Optum의 의료 서비스를 결합하여 고령 인구 동향의 직접적인 이익을 누립니다.

헬스케어 주식

UnitedHealth Group은 매출과 시가총액 모두에서 가장 큰 의료 보험 주식이며, 국내 최대 건강보험 사업과 빠르게 성장하는 Optum 의료 서비스 플랫폼을 결합하여 미국 의료 시스템의 거의 모든 측면을 다루는 수직 통합형 의료 기업을 만들었습니다.

Key Financials UNH

가격 $293.19
변동 (1일) +3.10%
변동 (30D) -11.18%
변동 (60D) -8.53%
변동 (90D) -18.28%
변동 (180D) -1.65%
변동 (1Y) -44.41%
변동 (5Y) -11.05%
P/E 비율 13.20
EPS (TTM) $22.21
52주 범위 $234.60 — $606.36
50일 MA $321.23
거래량 10.27M

Data updated Feb 15 · Source: Twelve Data

4.1
2 reviews
Demographic Exposure
4.7
Growth Potential
3.8
Dividend Reliability
3.5
Financial Stability
3.2
Regulatory Risk
2
Claude Opus 4.6
AI Review
3.7/5

UnitedHealth Group, the nation's largest health insurer and parent of Optum's healthcare services empire, has experienced a dramatic decline " down over 44% in the past year from its 52-week high of $606. The sell-off reflects a convergence of headwinds: rising medical costs, regulatory scrutiny, a DOJ investigation, and the tragic shooting of a subsidiary CEO that intensified public backlash against managed care. At a P/E of 13.2x with EPS of $22.21, the stock trades at a significant discount to historical multiples, potentially offering deep value for patient investors. The bull case centers on UNH's dominant market position in Medicare Advantage (directly benefiting from aging demographics), diversified revenue streams through Optum, and a track record of consistent earnings growth. The bear case includes elevated medical loss ratios, political risk around healthcare reform, potential regulatory actions, and questions about whether management can restore credibility. Trading well below its 50-day moving average of $321, momentum remains decidedly negative. However, UNH's structural advantages in serving an aging population and its integrated care model provide a durable competitive moat that makes this selloff worth monitoring closely.

Demographic Exposure
4.7
Growth Potential
3.8
Dividend Reliability
3.5
Financial Stability
3.2
Regulatory Risk
2
Feb 15, 2026
Gemini 3 Pro Preview
AI Review
4.4/5

UnitedHealth Group remains a dominant force in the healthcare sector, leveraging its integrated model of insurance (UnitedHealthcare) and health services (Optum) to drive long-term growth. The provided financial data indicates the stock is currently trading at a P/E ratio of 12.30, a valuation that appears remarkably attractive relative to historical norms for such a high-quality compounder. While the share price has retreated significantly from its 52-week high of $606.36, creating a bearish technical setup below the 50-day moving average, the company's earnings power remains resilient with an EPS of $22.21. Investors must weigh the attractive valuation against risks like regulatory scrutiny on Medicare Advantage and rising medical loss ratios. However, for value-oriented investors, UNH presents a potential opportunity to acquire a sector leader at a discounted multiple.

Feb 11, 2026
UnitedHealth Group Screenshot

Added: Feb 10, 2026

unitedhealthgroup.com

Latest from Otrai

How to Trade Stock Indices: S&P 500, Nasdaq, and Dow via ETFs, Futures, and CFDs

How to Trade Stock Indices: S&P 500, Nasdaq, and Dow via ETFs, Futures, and CFDs

A stock index is a single number that summarizes the price action of a basket of companies. The S&P 500 tracks roughly 500 large US firms, the Nasdaq-100 tracks the 100 largest non-financial names on the Nasdaq exchange, and the Dow Jones Industrial Average follows 30 blue-chip stocks.

The Options Greeks Explained: Delta, Gamma, Theta, and Vega

The Options Greeks Explained: Delta, Gamma, Theta, and Vega

The Greeks explain why an option costs what it costs and how that price changes when the stock moves, time passes, and volatility shifts. Delta, Gamma, Theta, and Vega, made accessible.

Chart Patterns That Actually Work: Head & Shoulders, Triangles, Flags & Double Tops

Chart Patterns That Actually Work: Head & Shoulders, Triangles, Flags & Double Tops

Chart patterns are the most recognizable part of technical analysis and the most misunderstood. Most fail or break out the wrong way before reversing. This guide covers head and shoulders, double tops and bottoms, triangles, and flags — with realistic reliability, target measurement, and false-breakout confirmation.

트레이딩 전략을 백테스트하는 방법: 방법론, 함정, 그리고 결과가 실제로 의미하는 것

트레이딩 전략을 백테스트하는 방법: 방법론, 함정, 그리고 결과가 실제로 의미하는 것

모든 트레이더는 머릿속으로는 훌륭해 보이는 전략을 가지고 있습니다. 백테스팅은 실제로 작동하는지 알아내는 방법입니다. 여기서는 전략을 올바르게 테스트하는 방법, 어떤 지표가 중요한지, 그리고 대부분의 백테스트 결과가 사실이기에는 너무 좋은 이유를 보여줍니다.